论文部分内容阅读
目的:研究阿奇霉素治疗小儿支原体肺炎的临床疗效。方法:选择于2012年6月至2013年7月在我院儿科就医的支原体肺炎患儿72例,所有患儿均通过入院前全面检查,且进行病情确诊,然后随机均分为两组,即研究组与对照组。各组患儿均为36例,其中对照组采用传统的红霉素进行治疗,而研究组则采用阿奇霉素进行治疗,同时对比各组患儿的治疗情况,计算整体治疗有效率。结果:根据本次研究结果显示,在治疗效果方面对比,研究组36例患儿整体治疗有效率为94.44%;而对照组36例患儿整体治疗有效率为58.33%;以上组间数据对比存在显著差异,满足统计学意义(P<0.05)。结论:对比传统红霉素治疗,以阿奇霉素治疗小儿支原体肺炎能够大大提升临床治疗效果,具有临床推广意义。
Objective: To study the clinical efficacy of azithromycin in the treatment of mycoplasma pneumonia in children. Methods: From June 2012 to July 2013, 72 children with mycoplasma pneumonia were admitted to our hospital for pediatric medicine. All children passed a thorough examination before admission and were diagnosed with the disease and then randomly divided into two groups Study group and control group. Each group of children were 36 cases, of which the control group using traditional erythromycin for treatment, while the study group was treated with azithromycin, while comparing the treatment of children in each group to calculate the overall treatment efficiency. Results: According to the results of this study, compared with the treatment effect, the overall treatment effective rate of 36 children in study group was 94.44%, while the overall treatment effective rate in 36 children in control group was 58.33%. The comparison of the above data Significant difference, to meet the statistical significance (P <0.05). Conclusion: Compared with the traditional treatment of erythromycin, azithromycin in children with mycoplasma pneumonia can greatly enhance the clinical effect of treatment, with clinical significance.